Pfizer Outlines Five-Point Plan to Battle COVID-19
March 14, 2020
March 14, 2020
NEW YORK, March 14 -- Pfizer, a pharmaceutical company, issued the following news release:
Pfizer issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19.
Dr. Albert Bourla, Chairman and CEO, made the following statement:
"In this troubling time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic. Many companies, including Pfizer, are . . .
Pfizer issued a five-point plan calling on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19.
Dr. Albert Bourla, Chairman and CEO, made the following statement:
"In this troubling time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic. Many companies, including Pfizer, are . . .